Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2022-03-15 Sale |
2022-03-17 5:58 pm |
Allogene Therapeutics Inc. | ALLO | SCHMIDT ERIC THOMAS Chief Financial Officer |
11,469 | $7.6337 | $87,551 | 1,253,141 (Indirect Direct) |
View |
| 2021-03-15 Sale |
2021-03-17 5:00 pm |
Allogene Therapeutics Inc. | ALLO | SCHMIDT ERIC THOMAS Chief Financial Officer |
8,053 | $38.23 | $307,889 | 1,223,826 (Indirect Direct) |
View |
| 2021-01-14 Sale |
2021-01-19 4:31 pm |
Allogene Therapeutics Inc. | ALLO | SCHMIDT ERIC THOMAS Chief Financial Officer |
30,000 | $31.52 | $945,469 | 1,231,511 (Indirect Direct) |
View |
| 2020-11-16 Sale |
2020-11-18 4:36 pm |
Allogene Therapeutics Inc. | ALLO | SCHMIDT ERIC THOMAS Chief Financial Officer |
15,000 | $32.88 | $493,146 | 1,261,511 (Indirect Direct) |
View |
| 2020-10-15 Sale |
2020-10-16 6:55 pm |
Allogene Therapeutics Inc. | ALLO | SCHMIDT ERIC THOMAS Chief Financial Officer |
15,000 | $40.49 | $607,392 | 1,276,511 (Indirect Direct) |
View |
| 2020-09-21 Sale |
2020-09-22 4:48 pm |
Allogene Therapeutics Inc. | ALLO | SCHMIDT ERIC THOMAS Chief Financial Officer |
15,000 | $35.3 | $529,545 | 1,291,741 (Indirect Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2023-06-08 Option Award |
2023-06-12 4:14 pm |
N/A 2033-06-07 |
Revolution Medicines Inc. | RVMD | SCHMIDT ERIC THOMAS Director |
23,600 | $0 | 39,651 (Direct) |
View |
| 2023-05-25 Option Award |
2023-05-30 5:09 pm |
2023-03-16 2032-12-16 |
RELMADA THERAPEUTICS INC. | RLMD | SCHMIDT ERIC THOMAS Director |
92,958 | $0 | 150,000 (Direct) |
View |
| 2023-03-22 Option Award |
2023-03-24 8:17 pm |
N/A 2033-03-22 |
Allogene Therapeutics Inc. | ALLO | SCHMIDT ERIC THOMAS Chief Financial Officer |
990,832 | $0 | 2,447,772 (Direct) |
View |
| 2023-03-14 Tax Withholding |
2023-03-16 5:08 pm |
N/A N/A |
Allogene Therapeutics Inc. | ALLO | SCHMIDT ERIC THOMAS Chief Financial Officer |
35,879 | $5.47 | 1,456,940 (Direct) |
View |
| 2022-12-16 Option Award |
2022-12-20 5:33 pm |
2023-03-16 2032-12-16 |
RELMADA THERAPEUTICS INC. | RLMD | SCHMIDT ERIC THOMAS Director |
57,042 | $0 | 57,042 (Direct) |
View |
| 2022-06-16 Option Award |
2022-06-17 5:04 pm |
N/A 2032-06-15 |
Revolution Medicines Inc. | RVMD | SCHMIDT ERIC THOMAS Director |
23,600 | $0 | 34,451 (Direct) |
View |
| 2022-05-25 Option Award |
2022-05-26 6:41 pm |
2022-03-17 2031-12-17 |
RELMADA THERAPEUTICS INC. | RLMD | SCHMIDT ERIC THOMAS Director |
91,235 | $0 | 150,000 (Direct) |
View |
| 2022-03-23 Option Award |
2022-03-25 5:49 pm |
N/A 2032-03-23 |
Allogene Therapeutics Inc. | ALLO | SCHMIDT ERIC THOMAS Chief Financial Officer |
605,947 | $0 | 1,859,088 (Direct) |
View |
| 2021-12-17 Option Award |
2021-12-21 9:31 pm |
2022-03-17 2031-12-17 |
RELMADA THERAPEUTICS INC. | RLMD | SCHMIDT ERIC THOMAS Director |
58,765 | $0 | 58,765 (Direct) |
View |
| 2021-06-22 Option Award |
2021-06-24 5:17 pm |
N/A 2031-06-21 |
Revolution Medicines Inc. | RVMD | SCHMIDT ERIC THOMAS Director |
16,276 | $0 | 23,510 (Direct) |
View |
| 2021-05-24 Exercise |
2021-05-26 08:00 am |
N/A N/A |
Allogene Therapeutics Inc. | ALLO | SCHMIDT ERIC THOMAS Chief Financial Officer |
14,897 | $18.22 | 1,358,292 (Direct) |
View |
| 2021-05-24 Exercise |
2021-05-26 08:00 am |
N/A 2030-03-18 |
Allogene Therapeutics Inc. | ALLO | SCHMIDT ERIC THOMAS Chief Financial Officer |
14,897 | $0 | 1,358,292 (Direct) |
View |
| 2021-03-26 Option Award |
2021-03-30 4:51 pm |
N/A 2031-03-26 |
Allogene Therapeutics Inc. | ALLO | SCHMIDT ERIC THOMAS Chief Financial Officer |
117,231 | $0 | 1,341,057 (Direct) |
View |
| 2021-01-07 Option Award |
2021-01-11 4:10 pm |
2021-04-07 2031-01-07 |
RELMADA THERAPEUTICS INC. | RLMD | SCHMIDT ERIC THOMAS Director |
100,000 | $0 | 100,000 (Direct) |
View |
| 2020-06-17 Option Award |
2020-06-19 3:33 pm |
N/A 2030-06-16 |
Revolution Medicines Inc. | RVMD | SCHMIDT ERIC THOMAS Director |
32,552 | $0 | 32,552 (Direct) |
View |